glycine has been researched along with Fatty Liver, Nonalcoholic in 17 studies
Excerpt | Relevance | Reference |
---|---|---|
" Glycine-β-muricholic acid (Gly-MCA) is an intestine-specific FXR antagonist previously shown to have favorable metabolic effects on obesity and insulin resistance." | 4.12 | Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice. ( Amin, SG; Desai, D; Gao, X; Gonzalez, FJ; Jiang, J; Krausz, KW; Liu, Y; Lu, D; Ma, Y; Patterson, AD; Xie, C, 2022) |
"Patients with chronic hepatitis C are expected to receive this treatment worldwide." | 2.52 | Does herbal medicine reduce the risk of hepatocellular carcinoma? ( Rino, Y; Yamamoto, N; Yukawa, N, 2015) |
"NAFLD and liver fibrosis were diagnosed using transient elastography and subjects were divided into three groups: normal, NAFLD, and liver fibrosis." | 1.56 | Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance. ( Endo, T; Fukuda, S; Hasegawa, T; Iino, C; Kimura, M; Mikami, K; Nakaji, S; Sawada, N, 2020) |
"Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease in developed countries." | 1.56 | Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease. ( Caussy, C; Loomba, R; Mills, PJ, 2020) |
"Glycine is a non-essential amino acid having multiple roles in many reactions." | 1.38 | Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats. ( Barakat, HA; Hamza, AH, 2012) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 11 (64.71) | 24.3611 |
2020's | 6 (35.29) | 2.80 |
Authors | Studies |
---|---|
Jiang, J | 1 |
Ma, Y | 1 |
Liu, Y | 2 |
Lu, D | 1 |
Gao, X | 1 |
Krausz, KW | 1 |
Desai, D | 1 |
Amin, SG | 1 |
Patterson, AD | 2 |
Gonzalez, FJ | 1 |
Xie, C | 1 |
Chen, D | 1 |
Liang, Y | 1 |
Liang, J | 1 |
Shen, F | 1 |
Cheng, Y | 1 |
Qu, H | 1 |
Wa, Y | 1 |
Guo, C | 1 |
Gu, R | 1 |
Qian, J | 1 |
Chen, X | 1 |
Zhang, C | 2 |
Guan, C | 1 |
Yamamoto, S | 1 |
Sato, I | 1 |
Fujii, M | 1 |
Kakimoto, M | 1 |
Honma, K | 1 |
Akiyama, N | 1 |
Sakai, M | 1 |
Fukuhama, N | 1 |
Kumazaki, S | 1 |
Hirohata, S | 1 |
Kitamori, K | 2 |
Yamori, Y | 1 |
Watanabe, S | 1 |
Vildhede, A | 1 |
Kimoto, E | 1 |
Pelis, RM | 1 |
Rodrigues, AD | 1 |
Varma, MVS | 1 |
Hasegawa, T | 1 |
Iino, C | 1 |
Endo, T | 1 |
Mikami, K | 1 |
Kimura, M | 1 |
Sawada, N | 1 |
Nakaji, S | 1 |
Fukuda, S | 1 |
Allen, J | 1 |
Zhang, J | 1 |
Quickel, MD | 1 |
Kennett, M | 1 |
Hankey-Giblin, PA | 1 |
Khukhlina, O | 1 |
Antoniv, A | 1 |
Kanovska, L | 1 |
Mandryk, O | 1 |
Smandych, V | 1 |
Mills, PJ | 1 |
Caussy, C | 1 |
Loomba, R | 1 |
Alves, A | 1 |
Bassot, A | 1 |
Bulteau, AL | 1 |
Pirola, L | 1 |
Morio, B | 1 |
Suzuki, Y | 1 |
Kaneko, R | 1 |
Nomura, M | 1 |
Naito, H | 1 |
Nakajima, T | 1 |
Ogawa, T | 1 |
Hattori, H | 1 |
Seno, H | 1 |
Ishii, A | 1 |
Rogue, A | 1 |
Anthérieu, S | 1 |
Vluggens, A | 1 |
Umbdenstock, T | 1 |
Claude, N | 1 |
de la Moureyre-Spire, C | 1 |
Weaver, RJ | 1 |
Guillouzo, A | 1 |
Rino, Y | 1 |
Yukawa, N | 1 |
Yamamoto, N | 1 |
Zang, S | 1 |
Wang, L | 1 |
Ma, X | 1 |
Zhu, G | 1 |
Zhuang, Z | 1 |
Xun, Y | 1 |
Zhao, F | 1 |
Yang, W | 1 |
Liu, J | 1 |
Luo, Y | 1 |
Ye, D | 1 |
Shi, J | 1 |
Zhou, X | 1 |
Han, D | 1 |
Xu, R | 1 |
Wu, H | 1 |
Qu, C | 1 |
Wang, F | 1 |
Wang, X | 1 |
Zhao, Y | 1 |
Mesnage, R | 1 |
Renney, G | 1 |
Séralini, GE | 1 |
Ward, M | 1 |
Antoniou, MN | 1 |
Mardinoglu, A | 1 |
Bjornson, E | 1 |
Klevstig, M | 1 |
Söderlund, S | 1 |
Ståhlman, M | 1 |
Adiels, M | 1 |
Hakkarainen, A | 1 |
Lundbom, N | 1 |
Kilicarslan, M | 1 |
Hallström, BM | 1 |
Lundbom, J | 1 |
Vergès, B | 1 |
Barrett, PH | 1 |
Watts, GF | 1 |
Serlie, MJ | 1 |
Nielsen, J | 1 |
Uhlén, M | 1 |
Smith, U | 1 |
Marschall, HU | 1 |
Taskinen, MR | 1 |
Boren, J | 1 |
Barakat, HA | 1 |
Hamza, AH | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters: A Clinical and Ex-vivo Study.[NCT03850314] | Phase 2/Phase 3 | 50 participants (Anticipated) | Interventional | 2019-03-31 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
2 reviews available for glycine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Glycine Metabolism and Its Alterations in Obesity and Metabolic Diseases.
Topics: Biological Availability; Diabetes Mellitus, Type 2; Diet; Gastrointestinal Microbiome; Glycine; Huma | 2019 |
Does herbal medicine reduce the risk of hepatocellular carcinoma?
Topics: Animals; Anti-Inflammatory Agents; Benzimidazoles; Carcinoma, Hepatocellular; Clinical Trials as Top | 2015 |
15 other studies available for glycine and Fatty Liver, Nonalcoholic
Article | Year |
---|---|
Glycine-β-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice.
Topics: Animals; Ceramides; Glycine; Intestines; Mice; Non-alcoholic Fatty Liver Disease; Obesity; Receptors | 2022 |
Beneficial effects of Lactobacillus rhamnosus hsryfm 1301 fermented milk on rats with nonalcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Body Weight; Cholesterol; D-Aspartic Aci | 2023 |
Increased Glycine-conjugated and Unconjugated Bile Acid Levels Associated with Aggravation of Nonalcoholic Steatohepatitis and Cardiovascular Disease in SHRSP5/Dmcr Rat.
Topics: Animals; Bile Acids and Salts; Cardiovascular Diseases; Glycine; Non-alcoholic Fatty Liver Disease; | 2023 |
Quantitative Proteomics and Mechanistic Modeling of Transporter-Mediated Disposition in Nonalcoholic Fatty Liver Disease.
Topics: Aniline Compounds; Chromatography, Liquid; Glucuronides; Glycine; Humans; Imino Acids; Membrane Tran | 2020 |
Changed Amino Acids in NAFLD and Liver Fibrosis: A Large Cross-Sectional Study without Influence of Insulin Resistance.
Topics: Adult; Aged; Aged, 80 and over; Amino Acids; Cross-Sectional Studies; Female; Glutamic Acid; Glycine | 2020 |
Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
Topics: Animals; Apolipoproteins E; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Collagen; Cytokines; D | 2018 |
EFFECTIVENESS OF NONALCOHOLIC STEATOHEPATITIS CORRECTION ON THE BAСKGROUND OF OBESITY WITH CONCOMITANT CHRONIC KIDNEY DISEASE.
Topics: Administration, Oral; Anti-Inflammatory Agents; Cysteine; Drug Administration Schedule; Drug Combina | 2018 |
Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease.
Topics: Carcinoma, Hepatocellular; Disease Progression; Glycine; Glyphosate; Humans; Liver; Liver Cirrhosis; | 2020 |
Simple and rapid quantitation of 21 bile acids in rat serum and liver by UPLC-MS-MS: effect of high fat diet on glycine conjugates of rat bile acids.
Topics: Animals; Bile Acids and Salts; Biomarkers; Calibration; Cholesterol, Dietary; Chromatography, Liquid | 2013 |
PPAR agonists reduce steatosis in oleic acid-overloaded HepaRG cells.
Topics: Cell Line; Constitutive Androstane Receptor; Drug Evaluation, Preclinical; Fatty Acids, Nonesterifie | 2014 |
Neutrophils Play a Crucial Role in the Early Stage of Nonalcoholic Steatohepatitis via Neutrophil Elastase in Mice.
Topics: Alanine Transaminase; Animals; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Apolipoprote | 2015 |
Glycine protects against high sucrose and high fat-induced non-alcoholic steatohepatitis in rats.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cytoprotection; Diet, High-Fat; Dietary Sucrose; Disea | 2016 |
Multiomics reveal non-alcoholic fatty liver disease in rats following chronic exposure to an ultra-low dose of Roundup herbicide.
Topics: Animals; Disease Models, Animal; Glycine; Glyphosate; Herbicides; Liver; Metabolomics; Non-alcoholic | 2017 |
Personal model-assisted identification of NAD
Topics: Animals; Disease Models, Animal; Female; Gene Expression Regulation, Enzymologic; Genome; Glutathion | 2017 |
Glycine alleviates liver injury induced by deficiency in methionine and or choline in rats.
Topics: Animals; Antioxidants; Choline Deficiency; Fatty Liver; Glycine; Lipid Metabolism; Lipid Peroxidatio | 2012 |